Overall, Align Technology demonstrates strong business quality through its diversified revenue streams, innovative product offerings, and robust practitioner engagement. However, pressures from foreign exchange rates and competition pose challenges. Future prospects remain positive, driven by growth in emerging markets and digital dentistry initiatives, but ASP declines and macroeconomic uncertainties present risks.
Analysis Date: February 5, 2025 Last Updated: May 29, 2025
+193%
+11.4% per year
Past performance does not guarantee future results. The data presented is indicative and may not be updated in real-time.
CountryUS
ExchangeNASDAQ
IndustryMedical - Devices
SectorHealthcare
Market Cap$16.50B
CEOMr. Joseph M. Hogan
Align Technology, Inc. is a company that makes dental products to help people straighten their teeth. Their most famous product is Invisalign, which are clear aligners that can replace traditional metal braces. They also create iTero scanners, which dentists use to take digital images of patients' mouths. These tools help orthodontists and dentists provide better care and make it easier for patients to achieve a healthy smile.
Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.
Graham Value Metrics
Benjamin Graham's value investing approach focuses on finding stocks with a significant margin of safety between their intrinsic value and market price.
📊
Unlock Graham value analysis
Access Benjamin Graham's value investing criteria, intrinsic value calculations, and margin of safety analysis
Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.
Income Statement Flow
Scroll horizontally to see more
About Profitability Metrics
Profitability metrics measure a company's ability to generate earnings relative to its revenue, operating costs, and other relevant metrics. Higher values generally indicate better performance.
📊
Unlock Profitability Metrics
Access detailed profitability metrics with visual gauges and benchmarks
ALGN Stock Analysis: Align Technology, Inc. Investment Guide
ALGN (Align Technology, Inc.) is a Healthcare company listed on NASDAQ Global Select. The stock has generated 11.4% annual returns with an overall investment score of None/100.
Overall, Align Technology demonstrates strong business quality through its diversified revenue streams, innovative product offerings, and robust practitioner engagement. However, pressures from foreign exchange rates and competition pose challenges. Future prospects remain positive, driven by growth in emerging markets and digital dentistry initiatives, but ASP declines and macroeconomic uncertainties present risks.
ALGN Key Financial Metrics
ALGN financial analysis includes comprehensive valuation ratios, profitability metrics, and financial health indicators. The company has a valuation score of 1.57234577809725/100 and profitability score of 3.75/100 with financial health rated 7.45/100.
About Align Technology, Inc.
Align Technology, Inc. is a company that makes dental products to help people straighten their teeth. Their most famous product is Invisalign, which are clear aligners that can replace traditional metal braces. They also create iTero scanners, which dentists use to take digital images of patients' mouths. These tools help orthodontists and dentists provide better care and make it easier for patients to achieve a healthy smile.
ALGN Investment Recommendation
Based on our comprehensive analysis of ALGN, investors should consider the company's strong performance track record, earnings consistency (9/10 quarters beat expectations), and current valuation metrics when making investment decisions.
Healthcare Sector Analysis
ALGN operates in the Medical - Devices industry within the Healthcare sector. This analysis compares Align Technology, Inc. performance against industry and sector benchmarks to provide context for investment decisions.
Frequently Asked Questions about ALGN Stock
Is ALGN a good investment?
ALGN (Align Technology, Inc.) has generated 11.4% annual returns with an overall score of None/100. Overall, Align Technology demonstrates strong business quality through its diversified revenue streams, innovative product offerings, and robust practitioner engagement. However, pressures from foreign exchange rates and competition pose challenges. Future … Investors should consider their risk tolerance and investment goals when evaluating ALGN.
What is ALGN P/E ratio and valuation?
ALGN valuation metrics including P/E ratio, price-to-book ratio, and price-to-sales ratio are analyzed on this page with comparisons to Medical - Devices industry and Healthcare sector benchmarks. The company currently has a valuation score of 1.57234577809725/100.
Should I buy ALGN stock now?
The decision to buy ALGN stock should be based on comprehensive analysis of financial metrics, market conditions, and individual investment goals. Our analysis provides profitability score of 3.75/100, financial health score of 7.45/100, and detailed performance metrics to help inform your investment decision.
What are ALGN financial health indicators?
ALGN financial health analysis includes liquidity ratios, debt levels, cash flow metrics, and profitability indicators. The company has a financial health score of 7.45/100 based on comprehensive analysis of balance sheet strength and operational efficiency.
How does ALGN compare to competitors?
ALGN performance is benchmarked against Medical - Devices industry peers and Healthcare sector averages. Our analysis includes comparative valuation ratios, profitability metrics, and growth indicators to provide context for Align Technology, Inc.'s market position.
What are ALGN historical returns?
ALGN has generated 11.4% annual returns over the 10Y. Historical performance analysis includes price appreciation, dividend yields, and total shareholder returns compared to market benchmarks.
ALGN Key Investment Metrics Summary
Annual Return: 11.4%
Valuation Score: 1.57234577809725/100
Profitability Score: 3.75/100
Financial Health Score: 7.45/100
Growth Score: -2.642236282066345/100
Earnings Beat Rate: 9/10 quarters
Sector: Healthcare
Industry: Medical - Devices
Exchange: NASDAQ Global Select
Market Cap: 16499828162
ALGN Investment Thesis
Align Technology, Inc. (ALGN) represents a strong investment opportunity in the Healthcare sector. With an overall score of None/100, the company demonstrates areas for financial improvement.
Investment Strengths
Strong Gross Profit Margin
Low Debt Levels
Strong Operating and Net Profit Margins
Healthy Return on Equity
Strong Liquidity Ratios
High Cash Per Share
Strong Revenue Growth Across Segments
Innovative Product Offerings
Strong Practitioner Engagement
Growth in Emerging Markets
Focus on Digital Dentistry
Projected Volume Growth
Investment Risks
High Price-to-Earnings Ratio
High EV/EBITDA Ratio
Interest Coverage Ratio Not Applicable
Pressure from Foreign Exchange Rates
Evolving Competitive Landscape
Anticipated ASP Declines
Macroeconomic Uncertainty
We use cookies to analyze site traffic and optimize your site experience.
By accepting, you consent to our use of cookies. Read our Privacy Policy to Learn more.